GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Silco Pharmaceuticals Ltd (DHA:SILCOPHL) » Definitions » Gross-Profit-to-Asset %

Silco Pharmaceuticals (DHA:SILCOPHL) Gross-Profit-to-Asset % : 0.00% (As of . 20)


View and export this data going back to 2019. Start your Free Trial

What is Silco Pharmaceuticals Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Silco Pharmaceuticals's annualized Gross Profit for the quarter that ended in . 20 was BDT Mil. Silco Pharmaceuticals's average Total Assets over the quarter that ended in . 20 was BDT 0 Mil. Therefore, Silco Pharmaceuticals's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 was Not Available.

Silco Pharmaceuticals Gross-Profit-to-Asset % Historical Data

The historical data trend for Silco Pharmaceuticals's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Silco Pharmaceuticals Gross-Profit-to-Asset % Chart

Silco Pharmaceuticals Annual Data
Trend
Gross-Profit-to-Asset %

Silco Pharmaceuticals Semi-Annual Data
Gross-Profit-to-Asset %

Competitive Comparison of Silco Pharmaceuticals's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Silco Pharmaceuticals's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Silco Pharmaceuticals's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Silco Pharmaceuticals's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Silco Pharmaceuticals's Gross-Profit-to-Asset % falls into.


;
;

Silco Pharmaceuticals Gross-Profit-to-Asset % Calculation

Silco Pharmaceuticals's annualized Gross-Profit-to-Asset % for the fiscal year that ended in . 20 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: . 20 )/( (Total Assets (A: . 20 )+Total Assets (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

Silco Pharmaceuticals's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is one times the annual (. 20) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Silco Pharmaceuticals Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Silco Pharmaceuticals's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Silco Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Silco Pharmaceuticals Ltd (DHA:SILCOPHL) » Definitions » Gross-Profit-to-Asset %
Comparable Companies
Traded in Other Exchanges
N/A
Address
41, Nurani, Bankolapara, Subidbazar, Sylhet, BGD, 3100
Website
https://www.silcopharma.com
Silco Pharmaceuticals Ltd is engaged in manufacturing and marketing of pharmaceuticals finished products in the categories of Antibiotics, Analgesics, Anti diabetics, Narcotics, Antipyratics, Anti-inflammatory Drugs, Antiulcerants, Multi medicines which are sold mainly in local market.

Silco Pharmaceuticals Headlines

No Headlines